Paid Clinical Trials Scottsdale

Discover 1,295 paid clinical trials in Scottsdale, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,295

DaratumumabDaratumumab Maintenance Therapy for Improving Survival in Patients With Light Chain Amyloidosis, EMILIA Trial

Recruiting

PHASE2

Sponsor:

Mayo Clinic

Location:

Scottsdale AZ, Rochester MN

Code:

NCT05898646

Conditions

AL Amyloidosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bone Marrow Aspiration

Daratumumab

Echocardiography

Questionnaire Administration

X-Ray Imaging

Observational StudyRegistry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

Recruiting

Sponsor:

Axogen Corporation

Location:

Phoenix AZ, Las Vegas NV, Orange CA, Lubbock TXshow 33 more

Code:

NCT01526681

Conditions

Peripheral Nerve Injuries

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Processed Human Nerve Graft

Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.

Autogenous Nerve Graft

Nerve Tube Conduit

Autologous Breast Reconstruction with Neurotization

Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Phoenix AZ, El Paso TX, Los Angeles CA, West Hollywood CAshow 59 more

Code:

NCT05156281

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

IptacopanA Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Glendale AZ, Las Vegas NV, San Diego CA, San Dimas CAshow 10 more

Code:

NCT04557462

Conditions

Primary IgA Nephropathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

LNP023

LY3556050A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Recruiting

PHASE2

Sponsor:

Eli Lilly and Company

Location:

Scottsdale AZ, Chandler AZ, Tucson AZ, Las Vegas NVshow 29 more

Code:

NCT06074562

Conditions

Diabetic Peripheral Neuropathy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY3556050

Placebo

CX-4945Dose-escalation Study of Oral CX-4945

Recruiting

PHASE1

Sponsor:

Cylene Pharmaceuticals

Location:

Scottsdale AZ, Loveland CO, Fort Collins CO, Houston TX

Code:

NCT00891280

Conditions

Advanced Solid Tumors

Breast Cancer

Inflammatory Breast Cancer

Castleman's Disease

Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CX-4945 oral formulation

BIIB091 & DRFA Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Recruiting

PHASE2

Sponsor:

Biogen

Location:

Scottsdale AZ, Albuquerque NM, Orange CA, Aurora COshow 19 more

Code:

NCT05798520

Conditions

Relapsing Forms of Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

BIIB091

DRF

Placebo

NTLA-2002HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Recruiting

PHASE3

Sponsor:

Intellia Therapeutics

Location:

Scottsdale AZ, Santa Monica CA, Colorado Springs CO, Centennial COshow 13 more

Code:

NCT06634420

Conditions

Hereditary Angioedema

Eligibility Criteria

Sex: All

Age: 16+

Healthy Volunteers: Not accepted

Interventions

NTLA-2002

Normal Saline IV Administration

VSV-hIFNβ-NIS, Cyclophosphamide, Ipilimumab, Nivolumab, CemiplimabA Vaccine (VSV-hIFNβ-NIS) with or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

Recruiting

PHASE1

Sponsor:

Mayo Clinic

Location:

Scottsdale AZ, Rochester MN

Code:

NCT03017820

Conditions

B-Cell Non-Hodgkin Lymphoma

Histiocytic and Dendritic Cell Neoplasm

Myelodysplastic Syndrome

Previously Treated Myelodysplastic Syndrome

Recurrent Adult Acute Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biopsy

Biospecimen Collection

Bone Marrow Biopsy

Computed Tomography

Cyclophosphamide

IMM-1-104A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Immuneering Corporation

Location:

Scottsdale AZ, San Diego CA, Duarte CA, Santa Monica CAshow 15 more

Code:

NCT05585320

Conditions

Advanced Solid Tumor

Pancreatic Adenocarcinoma

Malignant Melanoma (Cutaneous)

Non-small Cell Lung Cancer (NSCLC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

IMM-1-104 Monotherapy (Treatment Group A)

IMM-1-104 + modified Gemcitabine/nab-Paclitaxel (Treatment Group B)

IMM-1-104 + modified FOLFIRINOX (Treatment Group C)

IMM-1-104 + dabrafenib (Treatment Group D)

IMM-1-104 + pembrolizumab (Treatment Group E)